Development and validation of a risk scoring system to predict surgical-site infection after soft-tissue sarcoma resection: A single center retrospective study

Development and validation of a risk scoring system to predict surgical-site infection after soft-tissue sarcoma resection: A single center retrospective study - Development and validation of a risk scoring system to predict surgical-site infection after soft-tissue sarcoma resection: A single center retrospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049716

Enrollment

500

Registered

2022-12-07

Start date

2021-01-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

soft-tissue sarcoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with soft-tissue sarcoma who underwent surgical resection between January 2005 and December 2021

Exclusion criteria

Exclusion criteria: Incomplete information regarding the clinical parameter or treatment of the patients.

Design outcomes

Primary

Measure	Time frame
The associations of various variables (age, body mass index, diabetes, smoking during the previous year, tumor location, tumor depth, resected tumor size, operative time, skin graft or flap, preoperative chemotherapy, and radiation therapy) with SSI were evaluated in a cohort of 471 patients. Furthermore, a scoring system was developed by combining these risk factors, and the predictive power of the scoring system was evaluated in another cohort of 76 patients.	—

Measure

Time frame

The associations of various variables (age, body mass index, diabetes, smoking during the previous year, tumor location, tumor depth, resected tumor size, operative time, skin graft or flap, preoperative chemotherapy, and radiation therapy) with SSI were evaluated in a cohort of 471 patients. Furthermore, a scoring system was developed by combining these risk factors, and the predictive power of the scoring system was evaluated in another cohort of 76 patients.

—

Countries

Japan

Contacts

Public ContactShinji Miwa

Graduate School of Medical Science, Kanazawa University Department of Orthopedic Surgery

miwapoti@yahoo.co.jp0762652374

Outcome results